- Home
- DARE vs DRIO Comparison
DARE vs DRIO Comparison
Compare DARE & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- DRIO
- Stock Information
- Founded
- DARE 2015
- DRIO 2011
- Country
- DARE United States
- DRIO United States
- Employees
- DARE N/A
- DRIO N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- DARE Health Care
- DRIO Health Care
- Exchange
- DARE Nasdaq
- DRIO Nasdaq
- Market Cap
- DARE 26.3M
- DRIO 30.5M
- IPO Year
- DARE N/A
- DRIO N/A
- Fundamental
- Price
- DARE $2.38
- DRIO $0.68
- Analyst Decision
- DARE Strong Buy
- DRIO Strong Buy
- Analyst Count
- DARE 3
- DRIO 2
- Target Price
- DARE $12.50
- DRIO $2.50
- AVG Volume (30 Days)
- DARE 40.1K
- DRIO 170.3K
- Earning Date
- DARE 08-11-2025
- DRIO 08-07-2025
- Dividend Yield
- DARE N/A
- DRIO N/A
- EPS Growth
- DARE N/A
- DRIO N/A
- EPS
- DARE N/A
- DRIO N/A
- Revenue
- DARE $25,909.00
- DRIO $28,034,000.00
- Revenue This Year
- DARE $99,756.91
- DRIO $13.66
- Revenue Next Year
- DARE $119.77
- DRIO $24.50
- P/E Ratio
- DARE N/A
- DRIO N/A
- Revenue Growth
- DARE N/A
- DRIO 47.20
- 52 Week Low
- DARE $2.35
- DRIO $0.50
- 52 Week High
- DARE $4.60
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- DARE 34.73
- DRIO 47.18
- Support Level
- DARE $2.56
- DRIO $0.67
- Resistance Level
- DARE $2.95
- DRIO $0.73
- Average True Range (ATR)
- DARE 0.12
- DRIO 0.04
- MACD
- DARE -0.05
- DRIO -0.00
- Stochastic Oscillator
- DARE 8.45
- DRIO 43.39
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.